Access cutting-edge overactive bladder treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access overactive bladder specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related overactive bladder treatment provided free
Currently, in clinical practice there has been no standardization in the number of injections a single dose of intradetrusor onabotulinumtoxin A is administered in. Given the increasing use of this treatment modality, the aim of this study is to compare outcomes for patients given a 100 unit dose of onabotulinumtoxin A split into 5 as compared to 20 injections for the treatment of overactive bladder or urgency urinary incontinence refractory to medical treatment.
Sponsor: University of South Florida
Check if you qualify for this overactive bladder clinical trial in Washington Dc, DC
If you're searching for overactive bladder treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced overactive bladder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.